Veracyte Inc

NASDAQ:VCYT  
37.47
-0.72 (-1.88%)
Other Pre-Announcement, Mergers / Acquisitions

Veracyte To Acquire Haliodx, Positioning For Global Cancer Diagnostics Growth

Published: 06/01/2021 11:34 GMT
Veracyte Inc (VCYT) - Veracyte to Acquire Haliodx, Positioning for Global Cancer Diagnostics Growth.
Veracyte Inc - Reached Terms of an Agreement to Acquire Haliodx.
Veracyte Inc - at Closing, Veracyte Will Pay Approximately EUR 260 Million in Total Consideration to Haliodx Security Holders.
Veracyte Inc - Expects Acquisition of Haliodx to Be Accretive to Its Revenue Growth in 2021.
Veracyte Inc - Expects Deal to Expand Near-term Addressable Markets for Veracyte's Current and Pipeline Tests.
Veracyte Inc - Expects Transaction to Be Strategically Accretive to Its Gross Margins Once It Transitions Manufacturing of Test Kits to Haliodx.
Veracyte Inc - Haliodx's Operations and Laboratories Will Remain in Marseille, France and Richmond, Virginia.